Hubbell Incorporated (HUBB)

NYSEIndustrialsElectrical Equipment & PartsSnapshot 2026-10-15

$461.10-0.78%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Hubbell Incorporated’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.3%

+10% or more+5%0%−5%−10% or less

22.88 → 22.95 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

4 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Adjusted EPS growth to $19.3-$19.85 in 2026	Adjusted EPS is set to rise to about $19.5.	Intact	Adjusted EPS guidance falls below $18.0 for FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Manage debt and share buybacks prudently post-acquisition	A supporting condition in Hubbell Incorporated's published investment case. The stated target is Maintain stable leverage and continue buybacks without harming credit profile.	Intact	Leverage ratio rises above 3.5x or buybacks cease amid financial stress	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Increase EPS guidance to $17.45-$18.00 for 2026	A supporting condition in Hubbell Incorporated's published investment case. The stated target is EPS guidance >= $17.45.	Intact	EPS guidance falls below $16.5 for FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Achieve 8-11% total sales growth in 2026	A primary condition in Hubbell Incorporated's published investment case. The stated target is 8-11% YoY revenue growth.	Intact	YoY revenue growth falls below 6% in FY26	Revenue growth: 15.33% FY2026-Q2; GAAP. Published target: 8-11% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Jul 29, 202615.32709 percent · calculatedSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 60c8fd81-6e4f-41ba-ae4f-bf0effe08dae. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$22.95

$22.40 → $22.95 · observed estimates

FY2027 revenue$7.57B

$7.37B → $7.57B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$22.40	$7,366,363,630	8 / 7
2026-07-25	$22.13	$7,102,830,237	5 / 6
2026-07-26	$22.19	$7,120,794,887	5 / 5
2026-07-27	$22.19	$7,120,794,887	5 / 5
2026-07-28	$22.19	$7,120,794,887	5 / 5
2026-07-29	$22.42	$7,449,525,710	7 / 6
2026-07-30	$22.42	$7,449,525,710	7 / 6
2026-07-31	$22.87	$7,544,011,070	10 / 10
2026-08-01	$22.68	$7,425,817,491	6 / 7
2026-08-02	$22.68	$7,425,817,491	7 / 7
2026-08-03	$22.87	$7,544,011,070	10 / 10
2026-08-04	$22.87	$7,544,011,070	10 / 10
2026-08-05	$22.87	$7,544,011,070	10 / 10
2026-08-06	$22.87	$7,544,011,070	10 / 10
2026-08-07	$22.68	$7,425,819,166	7 / 7
2026-08-08	$22.87	$7,544,011,070	10 / 10
2026-08-09	$22.68	$7,425,819,166	7 / 7
2026-08-10	$22.68	$7,425,819,166	7 / 7
2026-08-12	$22.87	$7,544,011,070	10 / 10
2026-08-13	$22.68	$7,425,819,166	7 / 7
2026-08-14	$22.68	$7,425,819,166	7 / 7
2026-08-15	$22.68	$7,425,819,166	7 / 7
2026-08-16	$22.68	$7,425,819,166	7 / 7
2026-08-17	$22.68	$7,425,819,166	7 / 7
2026-08-18	$22.68	$7,425,819,166	7 / 7
2026-08-19	$22.68	$7,425,819,166	7 / 7
2026-08-20	$22.79	$7,485,964,197	7 / 7
2026-08-21	$22.79	$7,485,964,197	7 / 7
2026-08-22	$22.80	$7,498,551,098	7 / 8
2026-08-23	$22.80	$7,498,551,098	7 / 8
2026-08-24	$22.80	$7,498,551,098	7 / 8
2026-08-25	$22.80	$7,498,551,098	7 / 8
2026-08-26	$22.80	$7,498,551,098	7 / 8
2026-08-27	$22.80	$7,498,551,098	7 / 8
2026-08-28	$22.80	$7,498,551,098	7 / 8
2026-08-29	$22.80	$7,498,551,098	7 / 8
2026-08-30	$22.80	$7,498,551,098	7 / 8
2026-08-31	$22.80	$7,498,551,098	7 / 8
2026-09-01	$22.80	$7,498,551,098	7 / 8
2026-09-02	$22.80	$7,498,551,098	7 / 8
2026-09-03	$22.88	$7,561,326,062	7 / 8
2026-09-04	$22.88	$7,561,326,062	7 / 9
2026-09-05	$22.88	$7,561,326,062	7 / 9
2026-09-06	$22.88	$7,561,326,062	8 / 9
2026-09-07	$22.88	$7,561,326,062	8 / 9
2026-09-08	$22.88	$7,561,326,062	8 / 9
2026-09-09	$22.88	$7,561,326,062	8 / 9
2026-09-10	$22.88	$7,561,326,062	8 / 9
2026-09-11	$22.88	$7,561,326,062	8 / 9
2026-09-12	$22.88	$7,561,326,062	8 / 9
2026-09-13	$22.88	$7,561,326,062	8 / 9
2026-09-14	$22.88	$7,561,326,062	8 / 9
2026-09-15	$22.88	$7,561,326,062	8 / 9
2026-09-16	$22.88	$7,560,492,729	8 / 9
2026-09-17	$22.88	$7,560,492,729	8 / 9
2026-09-18	$22.88	$7,560,492,729	8 / 9
2026-09-19	$22.88	$7,560,492,729	8 / 9
2026-09-20	$22.88	$7,560,492,729	8 / 9
2026-09-21	$22.88	$7,560,492,729	8 / 9
2026-09-22	$22.90	$7,560,492,729	8 / 9
2026-09-23	$22.90	$7,560,492,729	8 / 9
2026-09-24	$22.90	$7,560,492,729	8 / 9
2026-09-25	$22.91	$7,571,384,673	8 / 9
2026-09-26	$22.91	$7,571,377,904	8 / 9
2026-09-27	$22.91	$7,571,377,904	8 / 10
2026-09-28	$22.91	$7,571,377,904	8 / 10
2026-09-29	$22.91	$7,571,377,904	8 / 10
2026-09-30	$22.91	$7,568,328,136	8 / 10
2026-10-01	$22.94	$7,573,693,985	8 / 10
2026-10-02	$22.94	$7,573,693,985	8 / 10
2026-10-03	$22.94	$7,573,700,754	8 / 10
2026-10-04	$22.94	$7,573,700,754	8 / 10
2026-10-05	$22.94	$7,573,700,754	8 / 10
2026-10-06	$22.94	$7,573,700,754	8 / 10
2026-10-07	$22.94	$7,572,546,908	8 / 10
2026-10-08	$22.94	$7,572,554,539	8 / 10
2026-10-09	$22.95	$7,573,785,308	7 / 10
2026-10-10	$22.95	$7,573,785,308	7 / 10
2026-10-11	$22.95	$7,573,785,308	7 / 10
2026-10-12	$22.95	$7,573,785,308	7 / 10
2026-10-13	$22.95	$7,573,785,308	7 / 10
2026-10-14	$22.95	$7,573,785,308	7 / 10
2026-10-15	$22.95	$7,573,785,308	7 / 10

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	7	7	1
2026-06-01	7	6	1
2026-07-01	6	6	1
2026-08-01	7	6	0
2026-09-01	7	7	0
2026-10-01	7	7	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 7 Buy / Strong Buy · 7 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 16–Oct 15 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Mizuho SecuritiesOct 15

$560.00New observation · no comparable prior

Evercore ISIOct 9

$630.00New observation · no comparable prior

Seaport GlobalSep 30

$580.00New observation · no comparable prior

Wells FargoSep 24

$531.00New observation · no comparable prior

$0$346.50$693.00

0 raises · 0 cuts · 0 unchanged · 4 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Adjusted EPS growth to $19.3-$19.85 in 2026Direct metric needs a verified mapping
Manage debt and share buybacks prudently post-acquisitionQualitative condition
Increase EPS guidance to $17.45-$18.00 for 2026Direct metric needs a verified mapping
Achieve 8-11% total sales growth in 2026Revenue growth: 15.33%

Next proof point

Oct 27, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.2%Typical daily move · historical

Downside history

-21.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Hubbell Incorporated outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

HUBB represents a durable compounder with a focus on organic sales growth and earnings per share (EPS) increases. The current thesis state is stable, but recent changes in confidence indicate some caution.

What's priced into Hubbell Incorporated

The market seems to price HUBB as relatively cheap compared to its peers, with a slight expectations gap. This suggests that while there is some fragility in execution, it is not fully reflected in the current valuation.

What the fundamentals likely do

Management is on track to achieve double-digit organic sales growth and increase adjusted diluted EPS in 2026. However, there is a moderate risk of missing expectations due to the high miss-rate in the industry, which requires close monitoring.

What Hubbell Incorporated hinges on

The thesis hinges on the performance of sector bellwethers like ETN, VRT, and BE. If these companies continue to perform well, HUBB may benefit from positive sector momentum. Conversely, any negative guidance from these peers could impact HUBB's outlook.